TOLVAPTAN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Tolvaptan.
| Product ID | 60505-4705_1bcbe7de-c01b-4ace-b2cf-8d663b3f92ed |
| NDC | 60505-4705 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TOLVAPTAN |
| Generic Name | Tolvaptan |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-05-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022275 |
| Labeler Name | Apotex Corp. |
| Substance Name | TOLVAPTAN |
| Active Ingredient Strength | 30 mg/1 |
| Pharm Classes | Vasopressin V2 Receptor Antagonist [EPC],Vasopressin V2 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-05-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022275 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-20 |
| Ingredient | Strength |
|---|---|
| TOLVAPTAN | 30 mg/1 |
| SPL SET ID: | ebae8c22-2abf-4b81-9bab-e068e798af48 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 31722-868 | Tolvaptan | Tolvaptan |
| 31722-869 | Tolvaptan | Tolvaptan |
| 49884-768 | Tolvaptan | Tolvaptan |
| 49884-770 | Tolvaptan | Tolvaptan |
| 60505-4704 | TOLVAPTAN | TOLVAPTAN |
| 60505-4705 | TOLVAPTAN | TOLVAPTAN |
| 67877-636 | Tolvaptan | Tolvaptan |
| 67877-637 | Tolvaptan | Tolvaptan |
| 59148-079 | Jynarque | tolvaptan |
| 59148-080 | Jynarque | tolvaptan |
| 59148-082 | JYNARQUE | tolvaptan |
| 59148-083 | JYNARQUE | tolvaptan |
| 59148-087 | Jynarque | tolvaptan |
| 59148-088 | Jynarque | tolvaptan |
| 59148-020 | SAMSCA | tolvaptan |
| 59148-021 | SAMSCA | tolvaptan |